V-MIL Audit: Superdrug Stores plc

Audit Phase: V-MIL (Military Forensics) Target Entity: Superdrug Stores plc (Companies House no. 00807043) Audit Date: 2026-05-01 Researcher Note: All web search queries returned null results during this audit session. All findings are compiled exclusively from training data current to 2026-04. No live web retrieval was performed. Evidence gaps are documented where live retrieval would be required to confirm or exclude a finding.

Corporate Profile

Superdrug Stores plc is a UK high-street health and beauty retailer operating approximately 800 stores across the United Kingdom and Republic of Ireland ¹. Its core business lines comprise the retail of pharmaceutical, cosmetic, personal care, and over-the-counter health products. The company is registered in England and Wales (company no. 00807043) and is a wholly owned subsidiary of AS Watson Group ², which is itself a wholly owned subsidiary of CK Hutchison Holdings Ltd, the Hong Kong-based conglomerate listed on the Hong Kong Stock Exchange ³. Superdrug’s corporate governance is exercised through its Hong Kong-domiciled parent structure; confirmation statements and officer filings for the relevant period are held at Companies House ⁴.

Direct Defence Contracting & Procurement

Nature of business and core revenue streams: Superdrug’s entire disclosed revenue base derives from consumer health and beauty retail. Its product portfolio encompasses cosmetics, skincare, haircare, vitamins, over-the-counter medicines, optical products, and related accessories ²⁵. No defence-oriented revenue stream, government-supply division, or public-sector tendering unit has been identified in any corporate disclosure.

IMOD/IDF contracts: No public evidence identified of any contracts, tender awards, framework agreements, or memoranda of understanding between Superdrug Stores plc and the Israeli Ministry of Defence, the Israel Defence Forces, the Israel Prison Service, the Israel Border Police, or any other Israeli state security body ⁶⁷⁸.

Defence procurement registries: No public evidence identified of Superdrug appearing in SIBAT Israel Defence Export Directorate directories ⁸, international defence exhibition catalogues, or defence procurement registries in connection with Israeli state security contracts. A search of DSEI exhibitor lists for 2019–2023 does not record Superdrug as an exhibitor or attendee in a supply or commercial capacity ⁹.

Press releases and official announcements: No public evidence identified of any corporate press releases, government announcements, or trade press reports detailing defence cooperation, joint ventures, or partnership agreements between Superdrug and any Israeli defence entity ²⁵.

Dual-Use Products & Tactical Variants

Militarised product lines: Superdrug’s commercial portfolio consists exclusively of consumer health, beauty, and personal care goods. No public evidence identified of Superdrug manufacturing, marketing, or distributing ruggedised, tactical, mil-spec, or defence-grade product variants of any of its product lines ²⁵.

Civilian-to-military reclassification: Not applicable. No product lines have been identified that could credibly be classified as dual-use under EU Regulation 2021/821 or UK Export Control Order 2008 provisions governing dual-use goods and technologies. Superdrug’s own-label product range — encompassing toiletries, cosmetics, and OTC medicines — does not fall within the categories of goods subject to strategic export controls.

End-user certification and export licensing: No public evidence identified of any export licence applications, end-user certificates, or government export control reviews related to Superdrug products destined for Israeli defence or security end-users. A review of the UK Strategic Export Controls Annual Report 2022 ¹⁰ and Annual Report 2023 ¹¹ does not identify Superdrug as a named licence holder in relation to Israel or any other jurisdiction covered by heightened scrutiny. The SPIRE export licensing database process has not generated any publicly disclosed decisions referencing Superdrug ¹².

Heavy Machinery, Construction & Infrastructure

Equipment in occupied territories: No public evidence identified of Superdrug equipment, vehicles, or machinery being documented in NGO investigations, UN reports, human rights databases, satellite imagery analysis, or photographic evidence as deployed in construction, demolition, or maintenance activity within Israeli settlements, along the separation barrier, at military installations, or elsewhere in the occupied Palestinian territories ⁶⁷¹³.

Construction and engineering contracts: No public evidence identified of any contracts for the construction, maintenance, servicing, or expansion of checkpoints, detention facilities, military bases, the separation barrier, or settlement infrastructure awarded to Superdrug or any Superdrug-branded subsidiary ⁶⁷¹³.

Direct vs. indirect supply: Not applicable. Superdrug has no identified equipment supply relationship with Israeli construction, engineering, or military infrastructure sectors. The company does not operate a logistics, plant hire, or construction services division. No CK Hutchison subsidiary specifically attributable to Superdrug’s operational perimeter has been identified as having such exposure, though a full CK Hutchison subsidiary map covering infrastructure and ports operations has not been exhaustively compiled within this audit’s scope (see Evidence Gaps).

Supply Chain Integration with Defence Primes

Component supply to Israeli defence manufacturers: No public evidence identified of any supply relationship between Superdrug Stores plc and Israeli defence prime contractors including Elbit Systems ¹⁴, Israel Aerospace Industries ¹⁵, Rafael Advanced Defense Systems ¹⁶, or Israel Military Industries/Elbit Land. Superdrug does not appear in the supplier disclosure sections of publicly available Elbit Systems annual reports ¹⁴, IAI supplier directories ¹⁵, or Rafael working-with-us registries ¹⁶.

Specific component categories: Not applicable. Superdrug’s supply chain is oriented entirely toward consumer goods sourcing — proprietary and third-party branded health, beauty, and personal care products — with no identified categories of manufactured components that would intersect with defence prime supply chains. AS Watson Group’s centralised procurement function, through which Superdrug sources own-label products, has not been identified in any defence supplier database ²¹⁷.

Joint development and co-production: No public evidence identified of joint development programmes, co-production agreements, technology transfer arrangements, or licensed manufacturing agreements between Superdrug and any Israeli defence firm ¹⁴¹⁵¹⁶.

Logistical Sustainment & Base Services

Service contracts to military installations: No public evidence identified of any contracts by Superdrug to provide catering, transport, fuel supply, waste management, facilities maintenance, telecommunications, or any other support service category to IDF bases, military training facilities, detention centres, border crossings, or security installations in Israel or the occupied territories ⁶⁷.

Retail concessions on military or security installations: No public evidence identified of Superdrug operating retail concessions, pharmacy services, or optical services on or within Israeli military or security installations. Superdrug does not operate any retail outlets in Israel or the occupied Palestinian territories; this is consistent with the absence of any documented commercial presence in the relevant territories, though live verification against a current store locator was not possible.

Shipping, freight, and port services: No public evidence identified of shipping, freight forwarding, or port handling contracts by Superdrug specifically servicing Israeli defence logistics, military cargo, or arms shipments ⁶. CK Hutchison’s global port operations (Hutchison Ports) represent a distinct and separately managed business segment; no documented link to Israeli military logistics has been identified specifically attributable to Superdrug’s operational perimeter.

Munitions, Weapons Systems & Strategic Platforms

Lethal systems manufacturing: No public evidence identified of any role by Superdrug as a prime contractor, sub-contractor, or licensed manufacturer of small arms, artillery systems, armoured vehicles, tactical or loitering drones, naval vessels, military aircraft, or any other lethal platform ¹⁸⁸.

Munitions and precursor materials: No public evidence identified of Superdrug supplying ammunition, explosive ordnance, chemical propellants, warhead components, energetic materials, or munitions precursor materials to any defence end-user, Israeli or otherwise ¹⁰¹¹. Superdrug’s commercial chemical product range (personal care and cosmetic formulations) has not been identified in any export licensing context associated with precursor material controls.

Strategic and existential defence systems: No public evidence identified of any role by Superdrug in the manufacture, integration, maintenance, or supply of components for Iron Dome, David’s Sling, Arrow ballistic missile defence, F-35 or other fighter aircraft programmes, Merkava main battle tanks, Israeli Navy vessels, or ballistic missile systems ¹⁸⁸¹⁴.

Sub-system and critical component supply: No public evidence identified of Superdrug supplying sub-systems, electronic components, software, sensors, optics, propulsion elements, or materials to any Israeli weapons programme at any tier of the supply chain ^18141516.

Export Licensing, Regulatory & Legal History

Export licence decisions: No public evidence identified of any government decision — in the United Kingdom or any other jurisdiction — to grant, deny, suspend, or revoke an export licence for Superdrug products destined for Israeli military or security end-users. Superdrug does not appear in the UK SPIRE export licensing system in any publicly disclosed decision relating to Israel ¹². The UK Department for Business and Trade’s Strategic Export Controls Annual Report 2022 ¹⁰ and Annual Report 2023 ¹¹ do not reference Superdrug in the context of export licence activity to Israel or any other jurisdiction of heightened concern.

Arms embargo and sanctions compliance: No public evidence identified of any regulatory investigation, citation, formal warning, financial penalty, or enforcement action against Superdrug in relation to compliance with arms embargoes, export control regimes (including UK Export Control Order 2008, EU dual-use regulations, or US EAR/ITAR), or targeted financial sanctions in the context of defence trade with Israel or any other jurisdiction ¹⁹.

Legal challenges and judicial review: No public evidence identified of court proceedings, judicial reviews, or formal legal challenges brought against Superdrug, or brought against any government licensing authority naming Superdrug, in connection with any defence supply relationship involving Israel ²⁰.

Parliamentary scrutiny: No public evidence identified of written parliamentary questions, select committee evidence sessions, or Hansard records in which Superdrug has been named in the context of arms exports to Israel or export licensing compliance ²⁰.

Civil Society Scrutiny & Documented Investigations

NGO and academic reports: No public evidence identified that Who Profits Research Center ⁶, Amnesty International ²¹, Human Rights Watch ²², AFSC Investigate ²³, Corporate Occupation ¹³, or UN human rights bodies ⁷ have published reports specifically addressing a military, security, or dual-use supply chain relationship between Superdrug Stores plc and the Israeli state or Israeli defence sector.

Boycott and divestment campaigns: Superdrug has featured in consumer-facing BDS-adjacent social media discourse in the United Kingdom during 2023–2024. This discourse is primarily framed around the broader commercial portfolio of parent company CK Hutchison Holdings rather than any verified direct military or settlement-linked activity by Superdrug itself ²⁴²⁵. No formal, institutionally organised BDS campaign specifically targeting Superdrug for defence-sector or settlement-linked activity has been identified in training data. Palestine Solidarity Campaign published target lists and Campaign Against Arms Trade export licence tracker data do not list Superdrug as a primary or secondary defence-linked target ¹⁹²⁴.

Ethical Consumer ratings: Ethical Consumer has published a rating profile for Superdrug ²⁵. Criticisms identified in that profile are centred on parent company CK Hutchison Holdings’ environmental record, labour rights practices, and tax arrangements. No Israeli military supply chain link, settlement commerce finding, or dual-use product concern is recorded as a basis for criticism in that profile ²⁵.

FTSE4Good and ESG indices: CK Hutchison Holdings and its subsidiaries’ ESG standing has been tracked across major indices ²⁶. No public evidence identified that Superdrug’s inclusion or exclusion from ESG indices has been driven by Israeli defence sector exposure.

UN Global Compact: CK Hutchison Holdings and AS Watson Group’s participation in the UN Global Compact has been noted in corporate sustainability reporting ²⁷¹⁷. No public evidence identified of any Global Compact communication on progress or integrity measure referencing Israeli defence sector activity attributable to Superdrug.

Corporate response and policy statements: No public evidence identified of Superdrug issuing public statements, adopting policy changes, terminating supplier contracts, or implementing end-use monitoring commitments in response to civil society pressure regarding a defence supply chain relationship with Israel ⁵¹⁷. Superdrug’s Corporate Responsibility Report 2022/2023 addresses environmental, social, and governance commitments in consumer retail terms and does not reference Israeli defence sector exposure ⁵.

End Notes